EyePoint Pharmaceuticals Overview
EyePoint Pharmaceuticals Discounted Cash Flow
DCF Analysis for EYPT.
Get informed when a big investor buys or sells
+ FollowFair Value
$-1.91
Current Fair Value
$-1.91
↓ 115.8% Downside
Overvalued by 115.8% based on the discounted cash flow analysis.
Average Upside/Downside (Comparison Companies)
Fair Value vs. Stock Price History
Upside/Downside History
Upside/Downside Comparison